Previously submitted to: JMIR mHealth and uHealth (no longer under consideration since Nov 09, 2025)
Date Submitted: Sep 15, 2025
Open Peer Review Period: Sep 22, 2025 - Nov 9, 2025
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
An ICT-Based Wearable Device Enhances Physical Function in Patients with Arteriosclerosis Obliterans: A 12-Week Intervention Study
ABSTRACT
Background:
Claudication, a characteristic manifestation of ASO, results from diminished blood flow due to arterial constriction. Engaging in a daily routine comprising moderate-to-vigorous physical activities (MVPAs) for a minimum of 30 min has been thoroughly substantiated as a viable strategy for preventing and managing cardiovascular pathologies. The body of academic research focusing on the enhancement of claudication gait using ICT-integrated wearable monitoring interventions is remarkably limited.
Objective:
This study examined the effects of a 12-week supervised exercise regimen employing an information and communication technology (ICT)-enabled wearable device on the physical functionality of individuals diagnosed with arteriosclerosis obliterans (ASO).
Methods:
In total, 52 participants (30 individuals with ASO and 22 healthy controls) were recruited and evaluated for grip strength, 6-min walk test (6MWT) distance, gait speed, five times sit-to-stand test, quality of life (World Health Organization quality-of-life assessment), and cognitive capability (Mini-Mental State Examination [MMSE] and Short-Form Geriatric Depression Scale).
Results:
Machine learning analysis revealed that gait speed and 6MWT distance were the most significant predictors of ASO. The intervention cohort exhibited noteworthy improvements in gait speed (from 1.09±0.18 to 1.14±0.16 m/s) and 6MWT distance (from 405.70±87.86 to 448.00±69.07 m) compared with the control group. The intervention cohort sustained moderate-to-vigorous physical activity (MVPA) levels exceeding 40 min/day, whereas the control group showed a decline from 30 min/day to 20 min/day. The adjusted models corroborated the significant disparities in gait speed, MMSE score, and 6MWT distance between the two groups.
Conclusions:
These results suggest that the ICT-based wearable device can efficiently facilitate and maintain MVPA levels in patients with ASO, culminating in enhanced gait functionality and diminished claudication symptoms. This methodology may offer a scalable framework for the remote rehabilitation of individuals with mobility-restricting vascular disorders. Clinical Trial: UMIN000059090
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.